Ipamorelin Peptide Pen - 10mg

Peptide Name

Ipamorelin 

CAS Number

• CAS Registry Number: 170851-70-4

Research Areas of Focus

Researchers are actively investigating Ipamorelin across several key physiological domains, including:

• Selective Pituitary Somatotroph Stimulation: Studying how the peptide selectively binds to the ghrelin/growth hormone secretagogue receptor (GHS-R1a) to induce growth hormone release without triggering elevations in cortisol, ACTH, or prolactin.

• Adipose Tissue Metabolism: Evaluating its direct and indirect impact on lipolysis, energy partition dynamics, and downstream fat metabolism in metabolic disease models.

• Gastrointestinal Motility and Gastric Emptying: Investigating its potential as a ghrelin receptor agonist to accelerate gastric transit times and alleviate severe gut dysmotility states (such as postoperative ileus).

• Bone Mineralization and Osteoblast Activity: Exploring the downstream effects of growth hormone secretagogue activity on bone mass retention, cortical bone density, and osteoblast-driven bone formation.

• Myofibrillar Preservation and Protein Synthesis: Assessing its capacity to mitigate skeletal muscle wasting and improve protein retention in cellular catabolic states.

RESEARCH-USE NOTICE

This product is supplied by Biolabs for laboratory and research purposes only. It is not intended to diagnose, treat, cure, or prevent any medical condition and should not be used as a substitute for professional medical advice or treatment.

Any information provided is for general research, product identification, storage, and handling purposes only. The purchaser is responsible for using and storing the product appropriately and in accordance with applicable regulations.